Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques
Authors:
- M C GarofaloMGM C Garofalo
- S J ChmuraSCS J Chmura
- K FarreyKFK Farrey
- C RashCRC Rash
- R HeimannRHR Heimann
- A B JaniAJA B Jani
- 1 June 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 79 (942) , 497-503
Abstract
The purpose of this study was to assess the efficacy and toxicity of intensity-modulated radiation therapy (IMRT) in the treatment of gastric cancer. Seven patients with gastric cancer were treated with IMRT. Six patients (all Stage III) received post-operative chemoradiotherapy with concurrent 5-fluorouracil and leucovorin. One received planned pre-operative radiation, though did not proceed to surgery. All patients were planned to receive 50.4 Gy in 1.8 Gy fractions. IMRT planning was compared with opposed anterior-posterior: posterior-anterior (AP/PA) and 3-field conventional three-dimensional plans. When compared with either AP/PA or 3-field plans, IMRT significantly reduced the volume exceeding the threshold dose of the liver and at least one kidney. Target coverage with IMRT was excellent, with 98+/-1% of the target receiving >or=100% of the dose. Compared with AP/PA and 3-field plans, IMRT plans had a greater percentage of target receiving the prescribed dose, but also a greater volume receiving >110% of the dose. IMRT was well tolerated; no patients developed acute gastrointestinal toxicity greater than grade 2. All seven experienced grade 2 nausea, three had grade 2 diarrhoea and two had grade 2 oesophagitis. Weight loss ranged from 0-12% (mean 6.1% and median 5.8%). IMRT in the treatment of gastric malignancies reduces the mean and above threshold doses to critical normal tissues. In an initial cohort of seven patients, 50.4 Gy delivered by IMRT is well tolerated and safe.Keywords
This publication has 18 references indexed in Scilit:
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcomeInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Comparative Evaluation of Gastric Carcinoma Staging: Japanese Classification Versus New American Joint Committee on Cancer/International Union Against Cancer ClassificationAnnals of Surgical Oncology, 2004
- Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Abdominal organ motion and deformation: implications for IMRTInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal JunctionNew England Journal of Medicine, 2001
- Evaluation of the new American Joint Committee on Cancer/International Union Against Cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classificationCancer, 1999
- Clinical Interpretation of Dose-Volume Histograms: The Basis for Normal Tissue Preservation and Tumor Dose Escalation1996
- Patterns of failure following curative resection of gastric carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1990
- Adenocarcinoma of the stomach: Areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982